Nisa Investment Advisors
APGE icon

Nisa Investment Advisors’s Apogee Therapeutics APGE Stock Holding History

Nisa Investment Advisors’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
1,012
+306
+43% +$27.6K ﹤0.01% 1406
2026
Q1 		$59.4K Buy
706
+5
+0.7% +$363 ﹤0.01% 1598
2025
Q4 		$52.9K Sell
701
-54
-7% -$3.4K ﹤0.01% 1601
2025
Q3 		$30K Sell
755
-14
-2% -$535 ﹤0.01% 1815
2025
Q2 		$33.4K Buy
769
+383
+99% +$14.6K ﹤0.01% 1721
2025
Q1 		$14.4K Sell
386
-42
-10% -$1.62K ﹤0.01% 2006
2024
Q4 		$19.4K Buy
428
+10
+2% +$510 ﹤0.01% 1946
2024
Q3 		$24.6K Buy
418
+60
+17% +$2.88K ﹤0.01% 1842
2024
Q2 		$14.1K Buy
358
+333
+1,332% +$16.2K ﹤0.01% 2057
2024
Q1 		$1.66K Buy
+25
New +$1.09K ﹤0.01% 2272

Other funds holding APGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

Nisa Investment Advisors's APGE Position: Q2 2026 in Review

Nisa Investment Advisors increased its Apogee Therapeutics (APGE) stake by 43% in Q2 2026, buying an estimated $27.6K and bringing the position to 1,012 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1406.

Nisa Investment Advisors first reported a position in APGE in Q1 2024 and has held it in 10 quarters since. 86 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Nisa Investment Advisors held 1,012 shares of Apogee Therapeutics worth $134K as of Q2 2026.
  • Nisa Investment Advisors bought 306 Apogee Therapeutics shares in Q2 2026, an estimated $27.6K.
  • Apogee Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1406 holding.
  • Nisa Investment Advisors first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 86 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.